Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.49 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.49 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.47 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.47 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4291365 | 1.00 | MEN1 (0.49) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| SCHEMBL270426 | 0.79 | MEN1 (0.66) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| SCHEMBL270425 | 0.79 | MEN1 (0.66) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| SCHEMBL29588234 | 0.79 | MEN1 (0.66) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| SCHEMBL3282776 | 0.78 | MEN1 (0.61) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| SCHEMBL3282773 | 0.78 | MEN1 (0.61) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| Methane SCHEMBL5133892 | 0.77 | ALDH1A1 (0.64) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| Hydrochloric Acid SCHEMBL28545676 | 0.77 | MEN1 (0.64) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| SCHEMBL1225987 | 0.77 | ALDH1A1 (0.55) | MEN1KMT2AALDH1A1MAPTRAB9A | |
| SCHEMBL672173 | 0.77 | ALDH1A1 (0.55) | MEN1KMT2AALDH1A1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5663055-A | Methods for diagnosing human influenza and 4-position modified chromogenic N-acetylneuraminic acid substrated for use therein | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0507854-B1 | METHODS FOR DIAGNOSING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN | SYMEX CORP (US) | 1996-11-27 | — | — | EP | claimed |
| EP-0507854-A4 | METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN | — | 1992-10-21 | — | — | EP | claimed |
| EP-0507854-A1 | METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN. | SYMEX CORP (US) | 1992-10-14 | — | — | EP | claimed |
| WO-1991010744-A1 | CHROMOGENIC 9-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH | SYMEX CORP. (US) | 1991-07-25 | — | — | WO | claimed |
| WO-1991009975-A1 | CHROMOGENIC 7- OR 8-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH | SYMEX CORP. (US) | 1991-07-11 | — | — | WO | claimed |
| WO-1991009972-A1 | METHODS FOR DIAGNOSTING HUMAN INFLUENZA AND 4-POSITION MODIFIED CHROMOGENIC N-ACETYLNEURAMINIC ACID SUBSTRATES FOR USE THEREIN | SYMEX CORP. (US) | 1991-07-11 | — | — | WO | claimed |
| WO-1991009971-A1 | CHROMOGENIC 5-POSITION MODIFIED NEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH | SYMEX CORP. (US) | 1991-07-11 | — | — | WO | claimed |
| US-8198436-B2 | Colorimetric detection of cyanide with a chromogenic oxazine | THE UNIVERSITY OF MIAMI (US) | 2012-06-12 | — | — | US | disclosed |
| US-20090258429-A1 | Colorimetric detection of cyanide with a chromogenic oxazine | MIAMI, THE UNIVERSITY OF | 2009-10-15 | — | — | US | disclosed |
| WO-2007028080-A1 | COLORIMETRIC DETECTION OF CYANIDE WITH A CHROMOGENIC OXAZINE | THE UNIVERSITY OF MIAMI (US) | 2007-03-08 | — | — | WO | disclosed |
| US-5663055-A | Methods for diagnosing human influenza and 4-position modified chromogenic N-acetylneuraminic acid substrated for use therein | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1997-09-02 | — | — | US | disclosed |
| WO-1991010744-A1 | CHROMOGENIC 9-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH | SYMEX CORP. (US) | 1991-07-25 | — | — | WO | disclosed |
| WO-1991009975-A1 | CHROMOGENIC 7- OR 8-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH | SYMEX CORP. (US) | 1991-07-11 | — | — | WO | disclosed |
| WO-1991009971-A1 | CHROMOGENIC 5-POSITION MODIFIED NEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH | SYMEX CORP. (US) | 1991-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258429-A1 | Colorimetric detection of cyanide with a chromogenic oxazine | CBR3, CBR1, CYCS | MEN1 4062/4885KMT2A 3788/4885ALDH1A1 2399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.